Skip to content

A Prospective Observational Study on the Association Between Amniotic Fluid Biomarkers and Intrauterine Infection During Pregnancy

A Prospective Observational Study on the Association Between Amniotic Fluid Biomarkers and Intrauterine Infection During Pregnancy - A Prospective Observational Study on the Association Between Amniotic Fluid Biomarkers and Intrauterine Infection During Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057879
Enrollment
50
Registered
2025-07-01
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women with suspected intrauterine infection

Interventions

None listed

Sponsors

Department of Obstetrics and Gynecology, Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Pregnant women receiving perinatal care at our institution (2) Cases in which intrauterine infection is suspected during pregnancy and amniotic fluid is collected for clinical purposes (3) Individuals who have provided written informed consent or are included based on opt-out procedures

Exclusion criteria

Exclusion criteria: (1) Cases in which amniotic fluid biomarker measurement was not performed (2) Cases in which pathological examination of the placenta and umbilical cord was not conducted after delivery (3) Cases in which a prolonged interval between amniotic fluid biomarker measurement and submission of placental pathological specimens is deemed analytically inappropriate

Design outcomes

Primary

MeasureTime frame
Presence or absence of histological chorioamnionitis

Countries

Japan

Contacts

Public ContactSHOKO SAITO

Tohoku University Hospital Department of Obstetrics and Gynecology

shoko_saito.y8k8@tohoku.ac.jp022-717-7251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026